ReviewGalen medical journal2024
A Comparative Study of the Application of Photobiomodulation Therapy in the Treatment of Temporomandibular Joint Diseases (TMD) : Photobiomodulation Therapy in the Treatment of TMD.
Review in Galen medical journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The primary objective of this trial was to evaluate the supplementary effect of photobiomodulation when added to orofacial myofunctional therapy on symptoms of Temporomandibular Disorder (TMD) in TMD. Materials and Methods: This pilot randomized trial investigated the effects of photobiomodulation on TMD symptoms. Eleven women with mild to moderate TMD were randomly assigned to either an experimental group (EG, n=5) receiving photobiomodulation combined with orofacial myofunctional therapy or a control group (CG, n=6) receiving passive orofacial myofunctional treatment alone. Participants underwent 12 sessions of treatment, with photobiomodulation administered using an 830nm laser at 48J/cm2 fluence. Outcome measures included pain levels and oral health-related quality of life. Results: The experimental group had considerably greater readings for all motions, including protrusion (P=0.037), sides (P=0.0025; P=0.0014), and opening (P=0.039), according to an examination of the groups. The control group's findings were statistically significant only for the measurements on the left and right (P=0.0030 and 0.0026, respectively). Numerous traits associated with mandibular mobility showed a discernible improvement before and after therapy in the EG. These variables include noise at the right and left temporomandibular joint (TMJ) during opening and closing of the mouth (P=0.019), noise at the right and left TMJ during protrusion (P=0.147; P=0.049), noise at the right and left TMJ during opening of the mouth (P=0.028; P=0.038), and noise at the left TMJ during opening of the mouth (P=0.012). There was only a reduction in left-sided pain (P=0.019) for the control group when comparing mandibular movements before and after treatment. Conclusion: In conclusion, photobiomodulation treatment improved orofacial myofunctional therapy results, which increased speech therapy's efficacy in treating temporomandibular disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.